Stem Cell - Analysis and Market Forecasts, 2006-2016 : Market Research Report

Stem Cell - Analysis and Market Forecasts, 2006-2016

Published: Mar. 1, 2007 - 350 Pages

Introduction and Overview: Stem Cell Therapies as Disruptive Technologies; Stem Cells as In Vivo Drug Stores; Stem Cell Plasticity; Stem Cell Safety
The History of Stem Cells as a Therapy
Trauma and Fracture: Trauma and Fracture Care; Types of Fractures; Causes of Fractures; The Biology of Fracture Healing; Stem Cell and Other Biologic Treatment of Fractures; Incidence of Fractures in the United States; Conventional Treatment of Fractures
Cranial Maxillofacial: Maxillofacial Trauma; Common Fractures of Facial Bones; Stem Cell Approach for Treatment of Cranial Maxillofacial Fractures; Conventional Treatment for Common Types of Facial Fractures
Cartilage Repair: The Biology of Cartilage; Causes of Cartilage Injury; Cellular Approaches to Cartilage Repair; Conventional Treatment for Cartilage Repair; Implant and Transplant Therapies; Large Joint Reconstruction
Large Joint Revision: Large Joint Revision Surgery
Cardiovascular Disease: Basics of Cardiovascular Disease; Cardiovascular Disease—the Most Common Cause of Death Globally; Risk Factors for Cardiovascular Disease; Types of Cardiovascular Disease; Stem Cell Treatment of Cardiovascular Disease; Traditional Treatment of Coronary Heart Disease; Treatment of Stroke
Nerve Regeneration: The Human Nervous System; Peripheral Nervous System; Types of Nerve Injuries; Nerve Regeneration and Recovery; Stem Cell Approach for Nerve Regeneration; Surgical Procedures for Nerve Injuries; Carpal Tunnel Syndrome
Anti-Inflammation: Mechanism of Action of Stem Cells in Mediating Inflammation in Humans
Diabetes: The Basics of Diabetes; Diabetes—A Leading Cause of Death Worldwide; Stem Cell Approach; Challenges Faced by the Stem Cell Approach; Diabetes Management—The Conventional Approach
Company Profiles: DM Inc; Aastrom Biosciences, Inc; Advanced Cell Technology, Inc; Aegera Therapeutics Inc; Aldagen, Inc; AllCells LLC; Amersham Biosciences; Amgen; Angel Biotechnology; Applied Tissue Technologies LLC; Arteriocyte, Inc; Athersys, Inc; BeFutur Biotechnologies SA; Berlex, Inc; BioE, Inc; BioHeart, Inc; Cambrex Corporation; Cell Dynamics, LLC; Cell Genesys, Inc; Cellartis AB; Cellerant Therapeutics, Inc; Cellerix SL; CellGenix Technologie Transfer GmbH; CellResearch Corp Pte Ltd; CellTran Limited; Cellular Dynamics International Inc; Ceregene Inc; Chemokine Therapeutics Corp; Cognate BioServices, Inc; CorCell; Covance Inc; Cytomatrix LLC; Cytori Therapeutics, Inc; EmCell; ES Cell International PTE Ltd; Gamida Cell Ltd; Geron Corporation; Histostem Co Ltd; Incxyte Corporation; Intercytex Group plc; Ixion Biotechnology, Inc; Kaleidos Pharma, Inc; Living Cell Technologies Ltd; MD Biosciences Inc; Mesoblast Limited; MG Biotherapeutics, LLC; Moraga Biotechnology; NeoStem, Inc; NeuralStem Biopharmaceuticals, Ltd; NeuroNova AB; Neuronyx, Inc; Novartis AG; Novocell, Inc; NsGene A/S; Odontis Ltd; Oligene GmbH; Ortec International, Inc; PharmaStem Therapeutics, Inc; Pluristem Life Systems, Inc; Progenitor Cell Therapy, LLC; Proneuron Biotechnologies Inc; Quintiles Transnational Corp; RegeneRx Biopharmaceuticals, Inc; Regenetech, Inc; Regenics A/S; ReneMed Biologics, Inc; ReNeuron Group PLC; Reproductive Genetics Institute; Saneron CCEL Therapeutics, Inc; (Bayer) Schering Pharma AG; Serologicals Corporation (acquired by Millipore); SinoCells BioTechnologies Co, Ltd; Stem Cell Sciences PLC; Stem Cell Therapeutics Corp; Stem Cells, Inc; StemCyte, Inc; StemCell Technologies Inc; StemPath Inc; Stemride International, Ltd; Tengion, Inc; TheraVitae Co, Ltd; Titan Pharmaceuticals, Inc; Transition Therapeutics Inc; TriStem Corporation; US Biodefense, Inc; Vesta Therapeutics, Inc; ViaCell, Inc; VistaGen Therapeutics Inc
APPENDIX

Abstract

Sales of stem cell products in the United States reached $16.4 million in 2006 and are expected to surpass $35 million in 2007, according to author Robin R. Young, a medical industry analyst who has been named one of The Wall Street Journal’s “Best on the Street” and among the top 10 analysts in the United States by Institutional Investor. By 2016, companies supplying stem cell products should generate more than $1.2 billion in total revenues and have a combined market value of over $10 billion. Find out about the latest stem cell applications and market trends through the Stem Cell Analysis and Market Forecasts 2006-2016. Over 350 pages of industry-specific research with forecasts and profiles of more than 100 stem cell companies.

Get Full Details About This Report >>

US: 800.298.5699

Int'l: +1.240.747.3093

About MarketResearch.com
MarketResearch.com is an online aggregator selling over 250,000 market research reports, company profiles and country profiles from over 650 research firms. Our reports will provide you with the critical business and competitive intelligence you need for strategic planning and marketing research. Coverage includes the US, UK, Europe, Asia and global markets.

Stem Cell - Analysis and Market Forecasts, 2006-2016

Table of Contents

Abstract